Affinivax
is a Massachusetts-based biopharmaceutical company that develops and commercializes novel vaccines for the treatment of infectious diseases... Read moreAffinivax
is a Massachusetts-based biopharmaceutical company that develops and commercializes novel vaccines for the treatment of infectious diseases... Read more
2014
News
Aug 17, 2022
Pharmaceutical Processing World
Affinivax: GSK finalizes Affinivax acquisition
Jun 21, 2022
FirstWord Pharma
Affinivax: Affinivax Presents Data for Enhanced Protection Against Serotype 3 in Next-Generation Pneumococcal Vaccine
Jun 10, 2022
Global Legal Chronicle
Affinivax: GSK's $3.3 Billion Acquisition of Affinivax
Jun 02, 2022
Medthority
Affinivax: GSK acquires Affinivax Inc. and its next-generation pneumococcal vaccines.
Jun 01, 2022
Business Recorder
Affinivax: Drugmaker GSK buys US vaccine firm for up to $3.3bn
May 31, 2022
FinanzNachrichten
Affinivax: GlaxoSmithKline Acquires US Vaccine Maker For Upto $3.3 Bln
May 31, 2022
MedCity News
Affinivax: GSK gets pneumococcal vaccine contender with $2.1B Affinivax acquisition
May 31, 2022
PharmaLive
Affinivax: GSK to spend up to $3.3 bln on Affinivax to boost vaccines roster
May 31, 2022
ValueWalk
Affinivax: GSK - Pads Out Pipeline Ahead Of Spin-Off
May 31, 2022
Sharecast
Affinivax: GlaxoSmithKline to buy US biotech Affinivax in $3.3bn deal
Affinivax Competitors
1
2
3
4
5
6
7
8
9
10